Recent transactions
| Filed | Insider | Role | Type | Shares | Price | Value | |
|---|---|---|---|---|---|---|---|
| Oct 29, 2026 | Schmitt Daniel M | Pres, CEO, Dir | P Purchase | — | $0.36 | $50K | filing |
ACTUATE THERAPEUTICS Equity (ACTU) insider trades
ACTUATE THERAPEUTICS Equity (ACTU) insider trading activity (SEC Form 4). Over the trailing 90 days, ACTU insiders filed 1 purchases totalling $50K and 0 sales totalling $0 — net BUYING of $50K. Most recent filing: Oct 29, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.
Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
1
$50K
Sells (90d)
0
$0
Net (90d)
+$50K
net buying
Most recent
Oct 29, 2026